2m 2m 2m 2m 2m 2m 2m
CITIUS PHARMACTC (CTXR)
NASDAQ
$0.59+$0.02 (+4.21%)
Price as of Aug 03, 2026 10:05 AM EDT- $15.6MMarket Cap
- -55.81%1-Year Change
- BiotechnologyIndustry
CITIUS PHARMACTC (CTXR)
$0.59+$0.02 (+4.21%)
CTXR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.57 | ||
Change | -$0.06 (-9.81%) | ||
Open | $0.62 | ||
High | $0.63 | ||
Low | $0.56 | ||
Previous Close | $0.63 | ||
Volume | 249,382 | ||
30-Day Average Volume | 430,576 | ||
1-Week Change | 9.55% | ||
1-Month Change | -5.71% | ||
1-Year Change | -55.81% | ||
3-Year Change | -97.70% | ||
5-Year Change | -98.79% | ||
Fundamentals | |||
Shares Outstanding | 27.5M | ||
Total Assets | $132.5M | ||
Market Cap | $15.6M | ||
Enterprise Value | $311.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$28.1M | ||
Free Cash Flow | -$1.3M | ||
EBIT | -$28.3M | ||
EBITDA | -$28.3M | ||
Net Working Capital | -$23.3M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 187 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 11/26/2024 | ||
Earnings & Revenue